Emerging research on how craving and reward pathways work - and how they can change
Personalized treatment plans from licensed providers who specialize in behavior change.
Care tailored to your goals, your biology, and your life.
100% online. Your privacy is protected at every step.
Modern life can become dopamine overload.
Different habits. Similar reward pathways. Most approaches treat the surface condition. Quel works on what’s driving it — with physician-led care and modern therapeutics that may include certain GLP-1 medications when clinically appropriate.
Simple. Private. Personalized.
No labels required.
A licensed provider reviews your history and goals
Treatment may include GLP-1s and other evidence-informed therapies.
Care evolves with you.
Led by experts shaping the future of craving care.
Quel Health was founded by epidemiologist Marlene C. Lira, MPH, and physician-scientist Steven D. Klein, MD, PhD. Together, they combine expertise in clinical care, substance use, and healthcare innovation to make modern craving care more accessible, private, and human-centered.
Marlene leads Quel’s vision and growth, drawing on years of work in telehealth delivery, substance use research, and health policy. Steve is a triple-board-certified physician whose pioneering use of GLP-1 therapies for craving reduction has been featured in national media. Together they are reshaping how people regain agency over their choices.
Start with a private conversation.
More clarity
Less noise
100% confidential
Licensed providers
Built around you
